Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | CA2 | P00918 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | TP53 | P04637 | 2/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | CASP1 | P29466 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | KDR | P35968 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 5-Chlorosalicylic Acid SCHEMBL130605 | 1.00 | CA1 (1.00) | CA1CA2ALDH1A1TP53PTGS2 | |
| 5-Chlorosalicylic Acid SCHEMBL27673653 | 0.98 | CA1 (0.96) | CA1CA2ALDH1A1TP53PTGS2 | |
| 5-Chlorosalicylic Acid SCHEMBL11158036 | 0.98 | CA1 (0.96) | CA1CA2ALDH1A1TP53PTGS2 | |
| 5-Chlorosalicylic Acid SCHEMBL27653684 | 0.98 | CA1 (0.96) | CA1CA2ALDH1A1TP53PTGS2 | |
| 5-Chlorosalicylic Acid SCHEMBL27673709 | 0.98 | CA1 (0.96) | CA1CA2ALDH1A1TP53PTGS2 | |
| 5-Chlorosalicylic Acid SCHEMBL943143 | 0.98 | CA1 (0.96) | CA1CA2ALDH1A1TP53PTGS2 | |
| 5-Chlorosalicylic Acid SCHEMBL27653659 | 0.98 | CA1 (0.96) | CA1CA2ALDH1A1TP53PTGS2 | |
| 5-Chlorosalicylic Acid SCHEMBL6855770 | 0.98 | CA1 (0.96) | CA1CA2ALDH1A1TP53PTGS2 | |
| 5-Chlorosalicylic Acid SCHEMBL27486520 | 0.98 | CA1 (0.96) | CA1CA2ALDH1A1TP53PTGS2 | |
| 5-Chlorosalicylic Acid SCHEMBL27653682 | 0.98 | CA1 (0.96) | CA1CA2ALDH1A1TP53PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4045480-A1 | PHARMACEUTICAL FORMULATIONS | First Wave Bio, Inc. (US) | 2022-08-24 | — | — | EP | claimed |
| EP-4713320-A2 | BCAT2 INHIBITORS | Agios Pharmaceuticals, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20260041093-A1 | Ionic Derivatives Of Aromatic Carboxylic Acid For Use As Plant Stimulants, Method For Stimulating Plants And Use Of These Derivatives For Manufacturing Compositions For Stimulating Plants | FUNDACJA UNIWERSYTETU IM. ADAMA MICKIEWICZA W POZNANIU (PL) | 2026-02-12 | — | — | US | disclosed |
| EP-4688198-A1 | FORMATION OF CO-CRYSTALS | Indicatrix Crystallography Ltd. (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-4642751-A2 | IONIC DERIVATIVES OF AROMATIC CARBOXYLIC ACID FOR USE AS PLANT STIMULANTS, METHOD FOR STIMULATING PLANTS AND USE OF THESE DERIVATIVES FOR MANUFACTURING COMPOSITIONS FOR STIMULATING PLANTS | Fundacja Uniwersytetu im. Adama Mickiewicza w Poznaniu (PL) | 2025-11-05 | — | — | EP | disclosed |
| EP-4605724-A1 | ANOMALY DETECTION IN AN ENVIRONMENT USING SINGLE PARTICLE AEROSOL MASS SPECTRA | Zeteo Tech, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12398097-B2 | WDR5-MYC inhibitors | VANDERBILT UNIVERSITY (US) | 2025-08-26 | — | — | US | disclosed |
| WO-2024238820-A2 | BCAT2 INHIBITORS | AGIOS PHARMACEUTICALS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| WO-2024201069-A1 | FORMATION OF CO-CRYSTALS | Indicatrix Crystallography Ltd. (GB) | 2024-10-03 | — | — | WO | disclosed |
| WO-2024192141-A1 | TREATMENT OF CANCERS HAVING A DRUG-RESISTANT MESENCHYMAL CELL STATE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-09-19 | — | — | WO | disclosed |
| WO-2024086326-A1 | ANOMALY DETECTION IN AN ENVIRONMENT USING SINGLE PARTICLE AEROSOL MASS SPECTRA | ZETEO TECH, INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| EP-4304622-A1 | COMBINATION OF A MYRTLE EXTRACT AND A TRIPTERYGIUM WILFORDII EXTRACT FOR CONTROLLING C. ACNES-INDUCED INFLAMMATION | Pierre Fabre Dermo-Cosmétique (FR) | 2024-01-17 | — | — | EP | disclosed |
| CN-116751358-A | Recyclable high molecular weight salicylate green material | 北京化工大学 | 2023-09-15 | — | — | CN | disclosed |
| WO-2023163883-A1 | COMPOSITIONS AND METHODS FOR TREATING POUCHITIS | First Wave BioPharma, Inc. (US) | 2023-08-31 | — | — | WO | disclosed |
| EP-4093401-A1 | SALICYLAMIDE DERIVATIVES AND RELATED METHODS OF MAKING | The Board of Regents of the University of Texas System (US) | 2022-11-30 | — | — | EP | disclosed |
| WO-2022204397-A1 | TREATMENT OF LONG HAULERS SYNDROME WITH NICLOSAMIDE | First Wave Biopharma (US) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022189758-A1 | COMBINATION OF A MYRTLE EXTRACT AND A TRIPTERYGIUM WILFORDII EXTRACT FOR CONTROLLING C. ACNES-INDUCED INFLAMMATION | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2022-09-15 | — | — | WO | disclosed |
| US-20220289673-A1 | WDR5-MYC INHIBITORS | VANDERBILT UNIVERSITY | 2022-09-15 | — | — | US | disclosed |
| EP-4045480-A1 | PHARMACEUTICAL FORMULATIONS | First Wave Bio, Inc. (US) | 2022-08-24 | — | — | EP | disclosed |
| EP-3962479-A1 | KCNT1 INHIBITORS AND METHODS OF USE | Praxis Precision Medicines, Inc. (US) | 2022-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041093-A1 | Ionic Derivatives Of Aromatic Carboxylic Acid For Use As Plant Stimulants, Method For Stimulating Plants And Use Of These Derivatives For Manufacturing Compositions For Stimulating Plants | CHRM5, CHRM2, CHRM1 | CA1 1823/4885CA2 75/4885ALDH1A1 3688/4885 |
| US-20220289673-A1 | WDR5-MYC INHIBITORS | MYC, WDR5, MYCBP | CA1 4853/4885CA2 4637/4885ALDH1A1 3953/4885 |
| US-12398097-B2 | WDR5-MYC inhibitors | MYC, WDR5, MYCBP | CA1 4853/4885CA2 4637/4885ALDH1A1 3953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.